30791908|t|Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via PPARgamma/SIRT6/FoxO3a pathway after subarachnoid hemorrhage in rats.
30791908|a|BACKGROUND: Subarachnoid hemorrhage (SAH) is a life-threatening subtype of stroke with high mortality and disabilities. Retinoid X receptor (RXR) has been shown to be neuroprotective against ischemia/reperfusion injury. This study aimed to investigate the effects of the selective RXR agonist bexarotene on neuroinflammation in a rat model of SAH. METHODS: Two hundred male Sprague-Dawley rats were used. The endovascular perforation induced SAH. Bexarotene was administered intraperitoneally at 1 h after SAH induction. To investigate the underlying mechanism, the selective RXR antagonist UVI3003 and RXR siRNA or SIRT6 inhibitor OSS128167 was administered via intracerebroventricular 1 h before SAH induction. Post-SAH assessments including SAH grade, neurological score, brain water content, Western blot, and immunofluorescence were performed. RESULTS: The endogenous RXR and sirtuin 6 (SIRT6) protein levels were increased after SAH. Bexarotene treatment significantly reduced brain edema and improved the short-/long-term neurological deficit after SAH. Mechanistically, bexarotene increased the levels of PPARgamma and SIRT6; decreased the expression of phosphorylated FoxO3a (p-FoxO3a), IL-6, IL-1beta, and TNF-a; and inhibited the microglia activation and neutrophils infiltration at 24 h after SAH. Either UVI3003, OSS128167, or RXR siRNA abolished the neuroprotective effects of bexarotene and its regulation on protein levels of PPARgamma/SIRT6/p-FoxO3a after SAH. CONCLUSIONS: The activation of RXR by bexarotene attenuated neuroinflammation and improved neurological deficits after SAH. The anti-neuroinflammatory effect was at least partially through regulating PPARgamma/SIRT6/FoxO3a pathway. Bexarotene may be a promising therapeutic strategy in the management of SAH patients.
30791908	37	47	bexarotene	Chemical	MESH:D000077610
30791908	59	76	neuroinflammation	Disease	MESH:D000090862
30791908	81	90	PPARgamma	Gene	25664
30791908	91	96	SIRT6	Gene	299638
30791908	97	103	FoxO3a	Gene	294515
30791908	118	141	subarachnoid hemorrhage	Disease	MESH:D013345
30791908	145	149	rats	Species	10116
30791908	163	186	Subarachnoid hemorrhage	Disease	MESH:D013345
30791908	188	191	SAH	Disease	MESH:D013345
30791908	226	232	stroke	Disease	MESH:D020521
30791908	342	369	ischemia/reperfusion injury	Disease	MESH:D015427
30791908	444	454	bexarotene	Chemical	MESH:D000077610
30791908	458	475	neuroinflammation	Disease	MESH:D000090862
30791908	481	484	rat	Species	10116
30791908	494	497	SAH	Disease	MESH:D013345
30791908	540	544	rats	Species	10116
30791908	593	596	SAH	Disease	MESH:D013345
30791908	598	608	Bexarotene	Chemical	MESH:D000077610
30791908	657	660	SAH	Disease	MESH:D013345
30791908	742	749	UVI3003	Chemical	MESH:C525131
30791908	767	772	SIRT6	Gene	299638
30791908	783	792	OSS128167	Chemical	-
30791908	849	852	SAH	Disease	MESH:D013345
30791908	869	872	SAH	Disease	MESH:D013345
30791908	895	898	SAH	Disease	MESH:D013345
30791908	1032	1041	sirtuin 6	Gene	299638
30791908	1043	1048	SIRT6	Gene	299638
30791908	1086	1089	SAH	Disease	MESH:D013345
30791908	1091	1101	Bexarotene	Chemical	MESH:D000077610
30791908	1134	1145	brain edema	Disease	MESH:D001929
30791908	1180	1200	neurological deficit	Disease	MESH:D009461
30791908	1207	1210	SAH	Disease	MESH:D013345
30791908	1229	1239	bexarotene	Chemical	MESH:D000077610
30791908	1264	1273	PPARgamma	Gene	25664
30791908	1278	1283	SIRT6	Gene	299638
30791908	1328	1334	FoxO3a	Gene	294515
30791908	1338	1344	FoxO3a	Gene	294515
30791908	1347	1351	IL-6	Gene	24498
30791908	1353	1361	IL-1beta	Gene	24494
30791908	1367	1372	TNF-a	Gene	24835
30791908	1456	1459	SAH	Disease	MESH:D013345
30791908	1468	1475	UVI3003	Chemical	MESH:C525131
30791908	1477	1486	OSS128167	Chemical	-
30791908	1542	1552	bexarotene	Chemical	MESH:D000077610
30791908	1593	1602	PPARgamma	Gene	25664
30791908	1603	1608	SIRT6	Gene	299638
30791908	1611	1617	FoxO3a	Gene	294515
30791908	1624	1627	SAH	Disease	MESH:D013345
30791908	1667	1677	bexarotene	Chemical	MESH:D000077610
30791908	1689	1706	neuroinflammation	Disease	MESH:D000090862
30791908	1720	1741	neurological deficits	Disease	MESH:D009461
30791908	1748	1751	SAH	Disease	MESH:D013345
30791908	1762	1779	neuroinflammatory	Disease	MESH:D000090862
30791908	1829	1838	PPARgamma	Gene	25664
30791908	1839	1844	SIRT6	Gene	299638
30791908	1845	1851	FoxO3a	Gene	294515
30791908	1861	1871	Bexarotene	Chemical	MESH:D000077610
30791908	1933	1936	SAH	Disease	MESH:D013345
30791908	1937	1945	patients	Species	9606
30791908	Negative_Correlation	MESH:C525131	MESH:D000077610
30791908	Negative_Correlation	MESH:D000077610	MESH:D013345
30791908	Negative_Correlation	MESH:D000077610	MESH:D000090862
30791908	Positive_Correlation	MESH:D013345	299638
30791908	Negative_Correlation	MESH:D000077610	24835
30791908	Positive_Correlation	MESH:D000077610	MESH:D009461
30791908	Negative_Correlation	MESH:D000077610	MESH:D001929
30791908	Association	MESH:D000090862	25664
30791908	Positive_Correlation	MESH:D000077610	25664
30791908	Association	MESH:D000090862	299638
30791908	Positive_Correlation	MESH:C525131	25664
30791908	Association	MESH:D000090862	294515
30791908	Positive_Correlation	MESH:C525131	299638
30791908	Positive_Correlation	MESH:D000077610	299638
30791908	Negative_Correlation	MESH:D000077610	24498
30791908	Positive_Correlation	MESH:C525131	294515
30791908	Negative_Correlation	MESH:D000077610	24494
30791908	Negative_Correlation	MESH:D000077610	294515

